Rohan Manohar

Rohan Manohar has a diverse work experience spanning from 2002 to 2023. Rohan most recently worked at Mediar Therapeutics as the Director of Biology, starting in June 2023. Prior to this, they served as the Associate Director of Discovery Biology at Scholar Rock from April 2022 to May 2023. From March 2021 to April 2022, Rohan held the position of Principal Scientist at Takeda, and prior to that, they were a Senior Scientist at the same company from April 2019 to February 2021. Rohan'sexperience also includes being a Scientist II at Pliant Therapeutics from April 2018 to April 2019, and a Research Scientist in Fibrosis Biology at Gilead Sciences from February 2016 to April 2018. Before entering the industry, Rohan worked at Clontech as a Marketing Specialist I from March 2015 to January 2016. Rohan also completed a postdoctoral fellowship at Harvard Medical School, working on a project related to skeletal muscle regeneration from August 2012 to January 2015. Rohan began their research career as a Graduate Student Researcher at the University of Pittsburgh, where they worked on stem cell isolation and characterization in mouse and human gallbladders and liver. Rohan completed their undergraduate research at Denison University, focusing on investigating Neurotactin and the effects of the cancer gene Bcr-Abl on nervous system development in Drosophila melanogaster.

Rohan Manohar completed their Bachelor of Science degree in Biology and Chemistry from Denison University, where they studied from 2002 to 2006. Afterward, they pursued a PhD in Pathology at the University of Pittsburgh School of Medicine from 2006 to 2011. Prior to their undergraduate studies, Rohan Manohar attended Cathedral and John Connon High School, although the specific start and end years are not provided.